EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Jennifer Schranz, Ipsen

Ipsen's Jennifer Schranz on rethinking rare disease for women

Jennifer Schranz, SVP and Global Head of Rare Diseases, Ipsen, joins the podcast to discuss the burden faced by women with rare diseases.

ARS' Richard Lowenthal on his mission to transform allergy care

Richard Lowenthal, CEO, ARS Pharmaceuticals, reveals the company’s mission to address unmet needs in allergy care with its new nasal spray.
Martina Dempsey Astellas

Astellas’ Martina Dempsey on achieving equal footing for women in pharma

Martina Dempsey, VP of Commercial Strategy and Operations at Astellas Europe, discusses empowering women in the pharmaceutical industry.

World Mental Health Day with Boehringer Ingelheim’s Nedim Pipic

Nedim Pipic, Senior Vice President and Global Therapeutic Area Head for Mental Health, Boehringer Ingelheim marks World Mental Health Day.
ViiV Healthcare's Jean-Bernard Simeon

ViiV Healthcare’s Jean-Bernard Simeon on ending the HIV epidemic

Join JB, ViiV Healthcare Europe to explore the HIV landscape in Europe, the UNAIDS plan to end the epidemic by 2030 and more in this podcast.

Moderna’s Chantal Friebertshäuser on improving vaccine confidence

The EMJ GOLD podcast is back! Our first guest is Chantal Friebertshäuser, Senior Vice President and General Manager, EMEAC, Moderna.

Season 7 highlights: GOLD Medal Moments

The new season of the podcast is only a week away, so before we get started – why not have a listen to some of the best bits from Series 7?

Astellas’ Tadaaki Taniguchi on how to challenge the status quo

In this season finale of the podcast, Isabel speaks to Dr Tadaaki Taniguchi, Chief Medical Officer, Head of Medical and Development, Astellas Pharma.
We’ve noticed you’re accessing
from North/South America.